Status:
TERMINATED
Bright by Three (BB3) Effectiveness Study
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
Bright by 3
Children's Hospital Colorado
Conditions:
Developmental Delay
Eligibility:
All Genders
12-15 years
Phase:
NA
Brief Summary
The Investigators propose to conduct a pragmatic randomized controlled trial of 350 one to four year old children and their caregivers to study the effectiveness of 1) the Bright By Three (BB3) interv...
Eligibility Criteria
Inclusion
- Low-income (based on insurance status of child being Medicaid or CHIP),
- Lower educational level (less than college level education) parents of 12 to 15 month old children from the Rocky Mountain Youth Clinic and the Child Health Clinic who speak either English or Spanish or both and their 12-15 month old toddlers.
Exclusion
- Parents with children born prior to 36 weeks gestation (premature infants)
- Children with chronic conditions known to affect neuro-development, such as trisomy 21, or
- Children who have a positive screen on the Children with Special Health Care Needs screener 57
- Parents who have already participated in the BB3 program
- Parents without access to a smart phone
- Parents who cannot read or converse in either English or Spanish
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02717390
Start Date
August 1 2017
End Date
March 30 2019
Last Update
November 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado AMC
Aurora, Colorado, United States, 80045